Literature DB >> 29292606

OPTN/SRTR 2016 Annual Data Report: Intestine.

J M Smith1,2, T Weaver1, M A Skeans1, S P Horslen3, A M Harper4,5, J J Snyder1,6, A K Israni1,6,7, B L Kasiske1,7.   

Abstract

Despite improvements in medical and surgical treatment of intestinal failure, intestine transplant continues to play an important role. In 2016, a total of 147 intestine transplants were performed, 80 intestine-without-liver and 67 intestine-liver. Over the past decade, the age distribution of candidates waitlisted for intestine and intestine-liver transplant shifted from primarily pediatric to increasing proportions of adults. In 2016, 58.2% of candidates on the intestine list at any time during the year were aged younger than 18 years, with a decrease over time in those aged younger than 6 years and an increase in those aged 6-17 years. Adults accounted for 41.9% of candidates on the list at any time during the year, with a stable proportion of those aged 18-34 years and a decrease in those aged 35 years or older. By age, pretransplant mortality rate was highest for adult candidates at 11.7 per 100 waitlist years and lowest for children aged younger than 6 years at 2.2 per 100 waitlist years. For intestine transplants with or without a liver in 2009-2011, 1- and 5-year graft survival was 72.0% and 54.1%, respectively, for recipients aged younger than 18 years, and 70.5% and 44.1%, respectively, for recipients aged 18 years or older. .

Entities:  

Keywords:  Intestinal failure; intestine transplant; intestine-liver transplant; waiting list

Mesh:

Year:  2018        PMID: 29292606     DOI: 10.1111/ajt.14560

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool.

Authors:  Jianing Fu; Julien Zuber; Mercedes Martinez; Brittany Shonts; Aleksandar Obradovic; Hui Wang; Sai-Ping Lau; Amy Xia; Elizabeth E Waffarn; Kristjana Frangaj; Thomas M Savage; Michael T Simpson; Suxiao Yang; Xinzheng V Guo; Michelle Miron; Takashi Senda; Kortney Rogers; Adeeb Rahman; Siu-Hong Ho; Yufeng Shen; Adam Griesemer; Donna L Farber; Tomoaki Kato; Megan Sykes
Journal:  Cell Stem Cell       Date:  2018-11-29       Impact factor: 24.633

Review 2.  Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Authors:  Mai Sedki; Aijaz Ahmed; Aparna Goel
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 3.  Intestinal transplants: review of normal imaging appearance and complications.

Authors:  Bashir Hakim; Daniel T Myers; Todd R Williams; Shunji Nagai; John Bonnett
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

4.  Characterization of T cell immunophenotypes in intestinal transplantation: A pilot study.

Authors:  Marjorie-Anne R Guerra; Maura Rossetti; Zhenyu Zhang; Xinkai Zhou; Emily C Whang; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Douglas G Farmer; Elaine F Reed; Laura J Wozniak
Journal:  Transpl Immunol       Date:  2018-09-20       Impact factor: 1.708

Review 5.  Intestinal Organoids Generated from Human Pluripotent Stem Cells.

Authors:  Satoru Tsuruta; Hajime Uchida; Hidenori Akutsu
Journal:  JMA J       Date:  2019-12-27

Review 6.  High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity.

Authors:  Jianing Fu; Mohsen Khosravi-Maharlooei; Megan Sykes
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

Review 7.  Pediatric Intestinal Failure Review.

Authors:  Nisha Mangalat; Jeffrey Teckman
Journal:  Children (Basel)       Date:  2018-07-20

8.  Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab.

Authors:  Guido Trentadue; Gursah Kats-Ugurlu; Tjasso Blokzijl; Gilles Fh Diercks; Jan Willem Haveman; Klaas Nico Faber; Gerard Dijkstra
Journal:  Transplant Direct       Date:  2020-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.